| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,279 |
1,874 |
$45K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
802 |
641 |
$25K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
759 |
683 |
$22K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
269 |
266 |
$15K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
320 |
286 |
$8K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
598 |
551 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
469 |
408 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
432 |
227 |
$3K |
| 99000 |
|
336 |
325 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
311 |
225 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
43 |
38 |
$755.45 |
| 87428 |
|
47 |
20 |
$367.45 |
| 87400 |
|
26 |
12 |
$284.88 |
| 87807 |
|
15 |
15 |
$132.00 |
| 86756 |
|
13 |
13 |
$120.15 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
54 |
44 |
$108.01 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
13 |
13 |
$51.33 |